Syndax Pharmaceuticals Now on VARA Pro

Syndax Pharmaceuticals, a commercial-stage oncology innovator with two first-in-class products, has made its consensus estimates accessible on VARA Pro.

Dedicated to developing groundbreaking therapies in areas of significant unmet need, Syndax aims to reimagine cancer care. The company is focused on realizing the full potential of its pipeline, leveraging cutting-edge scientific research to deliver therapeutics that provide meaningful and differentiated clinical results.

You can now add Syndax to your watchlist and stay updated on company estimates through our social media channels.

Don’t have a VARA Pro account yet? Sign up for free here.